M. Pelster, M. Gordon, Justin Moser, T. Wise-Draper, J. C. Park, W. Iams, R. Zwirtes, J. Jennings, N. Miselis, Rui-Ru Ji, S. Loughhead, H. Bernstein, A. Sharei, A. Jimeno
{"title":"638 COMMANDER-001: SQZ-eAPC-HPV单药治疗和pembrolizumab联合治疗HPV16+复发、局部晚期或转移性实体瘤患者的1/2期、多中心、开放标签研究(试验正在进行中)","authors":"M. Pelster, M. Gordon, Justin Moser, T. Wise-Draper, J. C. Park, W. Iams, R. Zwirtes, J. Jennings, N. Miselis, Rui-Ru Ji, S. Loughhead, H. Bernstein, A. Sharei, A. Jimeno","doi":"10.1136/jitc-2022-sitc2022.0638","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"638 COMMANDER-001: a phase 1/2, first-in-human, multicenter, open label study of SQZ-eAPC-HPV as monotherapy and with pembrolizumab in patients with HPV16+ recurrent, locally advanced, or metastatic solid tumors (trial in progress)\",\"authors\":\"M. Pelster, M. Gordon, Justin Moser, T. Wise-Draper, J. C. Park, W. Iams, R. Zwirtes, J. Jennings, N. Miselis, Rui-Ru Ji, S. Loughhead, H. Bernstein, A. Sharei, A. Jimeno\",\"doi\":\"10.1136/jitc-2022-sitc2022.0638\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":398566,\"journal\":{\"name\":\"Regular and Young Investigator Award Abstracts\",\"volume\":\"56 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Regular and Young Investigator Award Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jitc-2022-sitc2022.0638\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regular and Young Investigator Award Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jitc-2022-sitc2022.0638","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
638 COMMANDER-001: a phase 1/2, first-in-human, multicenter, open label study of SQZ-eAPC-HPV as monotherapy and with pembrolizumab in patients with HPV16+ recurrent, locally advanced, or metastatic solid tumors (trial in progress)